Severe refractory fingertip ulcerations in a patient with scleroderma: Successful treatment with sildenafil

被引:0
作者
Colglazier, CL [1 ]
Sutej, PG [1 ]
O'Rourke, KS [1 ]
机构
[1] Wake Forest Univ, Rheumatol Sect & Immunol, Dept Internal Med, Baptist Med Ctr, Winston Salem, NC 27109 USA
关键词
scleroderma; ulceration; sildenafil; systemic sclerosis; cutaneous;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic sclerosis (scleroderma) is a multisystem fibrotic disease that commonly manifests with severe Raynaud's phenomenon and slow-healing cutaneous ulcerations. Reduced nitric oxide levels have been proposed to play a role in the pathogenesis of vascular disease in scleroderma, and therefore sildenafil (which increases nitric oxide levels) is an attractive therapeutic prospect. We describe a patient with limited cutaneous systemic sclerosis who presented with severe nonhealing finger ulcerations despite conventional management, who showed marked improvement with oral sildenafil.
引用
收藏
页码:2440 / 2442
页数:3
相关论文
共 10 条
  • [1] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
    Badesch, DB
    Tapson, VF
    McGoon, MD
    Brundage, BH
    Rubin, LJ
    Wigley, FM
    Rich, S
    Barst, RJ
    Barrett, PS
    Kral, KM
    Jöbsis, MM
    Loyd, JE
    Murali, S
    Frost, A
    Girgis, R
    Bourge, RC
    Ralph, DD
    Elliott, CG
    Hill, NS
    Langleben, D
    Schilz, RJ
    McLaughlin, VV
    Robbins, IM
    Groves, BM
    Shapiro, S
    Medsger, TA
    Gaine, SP
    Horn, E
    Decker, JC
    Knobil, K
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 425 - +
  • [2] INCREASED LEVELS OF ENDOTHELIN-1 IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH SYSTEMIC-SCLEROSIS CONTRIBUTE TO FIBROBLAST MITOGENIC ACTIVITY IN-VITRO
    CAMBREY, AD
    HARRISON, NK
    DAWES, KE
    SOUTHCOTT, AM
    BLACK, CM
    DUBOIS, RM
    LAURENT, GJ
    MCANULTY, RJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (04) : 439 - 445
  • [3] Rational therapy in the treatment of systemic sclerosis
    Furst, DE
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (06) : 540 - 544
  • [4] Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
    Ghofrani, HA
    Wiedemann, R
    Rose, F
    Schermuly, RT
    Olschewski, H
    Weissmann, N
    Gunther, A
    Walmrath, D
    Seeger, W
    Grimminger, F
    [J]. LANCET, 2002, 360 (9337) : 895 - 900
  • [5] LYMPHOCYTE INTERACTIONS WITH THE VASCULAR ENDOTHELIUM IN SYSTEMIC-SCLEROSIS
    KAHALEH, B
    [J]. CLINICS IN DERMATOLOGY, 1994, 12 (03) : 361 - 367
  • [6] Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist
    Korn, JH
    Mayes, M
    Cerinic, MM
    Rainisio, M
    Pope, J
    Hachulla, E
    Rich, E
    Carpentier, P
    Molitor, J
    Seibold, JR
    Hsu, V
    Guillevin, L
    Chatterjee, S
    Peter, HH
    Coppock, J
    Herrick, A
    Merkel, PA
    Simms, R
    Denton, CP
    Furst, D
    Nguyen, N
    Gaitonde, M
    Black, C
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 3985 - 3993
  • [7] Severe digital ischaemia treated with phosphodiesterase inhibitors
    Kumana, CR
    Cheung, GTY
    Lau, CS
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) : 1522 - 1524
  • [8] MATUCCI CM, 2002, RHEUMATOLOGY, V41, P843
  • [9] Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the Raynaud phenomenon
    Rosenkranz, S
    Diet, F
    Karasch, T
    Weihrauch, J
    Wassermann, K
    Erdmann, E
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) : 871 - 873
  • [10] ZAMIRI B, 2004, EULAR 2004 M BERL GE